1,120
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Novel inhibitor of bacterial sphingomyelinase, SMY-540, developed based on three-dimensional structure analysis

, , , , , , , , , & show all
Pages 303-310 | Received 14 Nov 2012, Accepted 11 Feb 2013, Published online: 14 Mar 2013

References

  • Oda M, Hashimoto M, Takahashi M, et al. Role of sphingomyelinase in infectious diseases caused by Bacillus cereus. PLoS One 2012;7:e38054
  • Oda M, Takahashi M, Matsuno T, et al. Hemolysis induced by Bacillus cereus sphingomyelinase. Biochim Biophys Acta 2010;1798:1073–80
  • Ikezawa H, Mori M, Taguchi R. Studies on sphingomyelinase of Bacillus cereus: hydrolytic and hemolytic actions on erythrocyte membranes. Arch Biochem Biophys 1980;199:572–8
  • Ikezawa H, Matsushita M, Tomita M, Taguchi R. Effects of metal ions on sphingomyelinase activity of Bacillus cereus. Arch Biochem Biophys 1986;249:588–95
  • Ikezawa H, Mori M, Ohyabu T, Taguchi R. Studies on sphingomyelinase of Bacillus cereus. I. Purification and properties. Biochim Biophys Acta 1978;528:247–56
  • Ago H, Oda M, Takahashi M, et al. Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus. J Biol Chem 2006;281:16157–67
  • Oda M, Takahashi M, Tsuge H, et al. Role of side-edge site of sphingomyelinase from Bacillus cereus. Biochem Biophys Res Commun 2012;422:128–32
  • Openshaw AE, Race PR, Monzo HJ, et al. Crystal structure of SmcL, a bacterial neutral sphingomyelinase C from Listeria. J Biol Chem 2005;280:35011–17
  • Tajima A, Iwase T, Shinji H, et al. Inhibition of endothelial interleukin-8 production and neutrophil transmigration by Staphylococcus aureus beta-hemolysin. Infect Immun 2009;77:327–34
  • Nara F, Tanaka M, Hosoya T, et al. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties. J Antibiot (Tokyo) 1999;52:525–30
  • Nara F, Tanaka M, Masuda-Inoue S, et al. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J Antibiot (Tokyo) 1999;52:531–5
  • Uchida R, Tomoda H, Dong Y, Omura S. Alutenusin, a specific neutral sphingomyelinase inhibitor, produced by Penicillium sp. FO-7436. J Antibiot (Tokyo) 1999;52:572–4
  • Uchida R, Tomoda H, Arai M, Omura S. Chlorogentisylquinone, a new neutral sphingomyelinase inhibitor, produced by a marine fungus. J Antibiot (Tokyo) 2001;54:882–9
  • Inoue M, Yokota W, Murugesh MG, et al. Total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase. Angew Chem Int Ed Engl 2004;43:4207–9
  • Katoh T, Izuhara T, Yokota W, et al. Enantiocontrolled synthesis of the epoxycyclohexenone moieties of scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase. Tetrahedron 2006;62:1590–608
  • Inoue M, Yokota W, Katoh T. Enantioselective total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase. Synthesis 2007;4:622–37
  • Takagi R, Miyanaga W, Tojo K, et al. Stereoselective total synthesis of (+)-Scyphostatin via a pi-facially selective Diels-Alder reaction. J Org Chem 2007;72:4117–25
  • Fujioka H, Sawama Y, Kotoku N, et al. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase. Chem Eur J 2007;13:10225–38
  • Pitsinos E, Athinaios N, Xu Z, et al. Total synthesis of (+)-scyphostatin featuring an enantioselective and highly efficient route to the side-chain via Zr-catalyzed asymmetric carboalumination of alkenes (ZACA). Chem Comm 2010;46:2200–2
  • Arenz C, Giannis A. Synthesis of the first selective irreversible inhibitor of neutral sphingomyelinase. Angew Chem Int Ed Engl 2000;39:1440–2
  • Runcie KA, Taylor RJK. A short and efficient route to novel scyphostatin analogues. Org Lett 2001;3:3237–9
  • Arenz C, Gartner M, Wascholowski V, Giannis A. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase. Bioorg Med Chem 2001;9:2901–4
  • Pitsinos EN, Wascholowski V, Karaliota S, et al. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors. Chembiochem 2003;4:1223–5
  • Claus RA, Wustholz A, Muller S, et al. Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin. Chembiochem 2005;6:726–37
  • Wascholowski V, Giannis A. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase. Angew Chem Int Ed Engl 2006;45:827–30
  • Wascholowski V, Giannis A, Pitsinos EN. Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase. ChemMedChem 2006;1:718–21
  • Cha JY, Burnett GLT, Huang Y, et al. A strategy for the late-stage divergent syntheses of scyphostatin analogues. J Org Chem 2011;76:1361–71
  • Fraser CJ, Howell GP, Harrity JP. A furan Diels-Alder cycloaddition approach to scyphostatin analogues. Org Biomol Chem 2012;10:9058–66
  • Hakogi T, Monden Y, Iwama S, Katsumura S. Stereocontrolled synthesis of a sphingomyelin methylene analogue as a sphingomyelinase inhibitor. Org Lett 2000;2:2627–9
  • Hakogi T, Monden Y, Taichi M, et al. Synthesis of sphingomyelin carbon analogues as sphingomyelinase inhibitors. J Org Chem 2002;67:4839–46
  • Hakogi T, Taichi M, Katsumura S. Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor. Org Lett 2003;5:2801–4
  • Yokomatsu T, Takechi H, Akiyama T, et al. Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase. Bioorg Med Chem Lett 2001;11:1277–80
  • Taguchi M, Sugimoto K, Goda K, et al. Sphingomyelin analogues as inhibitors of sphingomyelinase. Bioorg Med Chem Lett 2003;13:1963–6
  • Imagawa H, Oda M, Takemoto T, et al. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors. Bioorg Med Chem Lett 2010;20:3868–71
  • Torley L, Silverstrim C, Pickett W. A turbidometric assay for phospholipase C and sphingomyelinase. Anal Biochem 1994;222:461–4
  • Fujii S, Nagata M, Morita M, et al. Novel inhibition mechanism of Bacillus cereus sphingomyelinase by beryllium fluoride. Arch Biochem Biophys 2004;424:201–9
  • Fujii S, Itoh H, Yoshida A, et al. Activation of sphingomyelinase from Bacillus cereus by Zn2+ hitherto accepted as a strong inhibitor. Arch Biochem Biophys 2005;436:227–36
  • Luberto C, Hassler DF, Signorelli P, et al. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 2002;277:41128–39
  • Suzuki H, Mori M, Shibakami M. Synthesis of ceramide mimics with a pseudo cyclic framework. Synlett 2003;14:2163–6
  • Garner P, Park J, Malecki E. A stereodivergent synthesis of D-erythro-sphingosine and D-threo-sphingosine from L-serine. J Org Chem 1988;53:4395–8
  • Garner P. Stereocontrolled addition to a penaldic acid equivalent: an asymmetric of threo-β-hydroxy-L-glutamic acid. Tetrahedron Lett 1984;25:5855–8
  • Arena G, Contino A, Longo E, et al. Synthesis, characterization of a novel calixarene having dipyridyl pendants and study of its complexes with Cu(II) and Co(II). Tetrahedron Lett 2003;44:5415–8
  • Thomas B, Lindemann C, Corcoran R, et al. Phosphonate lipid tubules II. J Am Chem Soc 2002;124:1227–33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.